Personal information

China

Biography

I received my Ph.D. degree in Medicinal Chemistry from China Pharmaceutical University and completed post-doctoral training at Emory University, focusing on the pathogenesis and drug development of neuropsychiatric disorders.

Activities

Employment (2)

Xiangya Hospital, Central South University: Changsha, Hunan, CN

Employment
Source: Self-asserted source
shilin Luo

The Second Xiangya Hospital of Central South University: Changsha, Hunan, CN

Employment
Source: Self-asserted source
shilin Luo

Works (10)

Disease-modifying therapies for Alzheimer’s disease: Clinical trial progress and opportunity

Ageing Research Reviews
2025-01 | Journal article
Contributors: Yujie Zhang; Jie Chen; Yanru Li; Bin Jiao; Shilin Luo
Source: check_circle
Crossref

The role of the probiotic Akkermansia muciniphila in brain functions: insights underpinning therapeutic potential

Critical Reviews in Microbiology
2023-03-04 | Journal article
Contributors: Ruiling Xu; Yuxuan Zhang; Shurui Chen; Yaohui Zeng; Xuan Fu; Ti Chen; Shilin Luo; Xiaojie Zhang
Source: check_circle
Crossref

Nonviral delivery systems for antisense oligonucleotide therapeutics

Biomaterials Research
2022-09-30 | Journal article
Contributors: Si Huang; Xin-Yan Hao; Yong-Jiang Li; Jun‑Yong Wu; Da-Xiong Xiang; Shilin Luo
Source: check_circle
Crossref

The Microglial membrane receptor TREM2 mediates exosome secretion to promote phagocytosis of amyloid‐β by microglia

FEBS Letters
2022-04 | Journal article
Contributors: Si Huang; Xiaoli Liao; Junyong Wu; Xiaojie Zhang; Yamin Li; Daxiong Xiang; Shilin Luo
Source: check_circle
Crossref

Correction: Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine

Molecular Psychiatry
2021-12-08 | Journal article
Part of ISSN: 1359-4184
Part of ISSN: 1476-5578
Source: Self-asserted source
shilin Luo

Polygonatum sibiricum Polysaccharides Protect against MPP‐Induced Neurotoxicity via the Akt/mTOR and Nrf2 Pathways

Oxidative Medicine and Cellular Longevity
2021-01 | Journal article
Contributors: Si Huang; Haiyan Yuan; Wenqun Li; Xinyi Liu; Xiaojie Zhang; Daxiong Xiang; Shilin Luo; Guodong Zhang
Source: check_circle
Crossref

Bushen-Tiansui Formula Improves Cognitive Functions in an Aβ1–42 Fibril-Infused Rat Model of Alzheimer’s Disease

Neural Plasticity
2020-09-24 | Journal article
Contributors: Chenxia Sheng; Panpan Xu; Xinyi Liu; Weijun Peng; Daxiong Xiang; Shilin Luo
Source: check_circle
Crossref

Osteogenesis activity of isocoumarin a through the activation of the PI3K-Akt/Erk cascade-activated BMP/RUNX2 signaling pathway

European Journal of Pharmacology
2019-09 | Journal article
Part of ISSN: 0014-2999
Source: Self-asserted source
shilin Luo

Akt Phosphorylates NQO1 and Triggers its Degradation, Abolishing Its Antioxidative Activities in Parkinson's Disease

The Journal of Neuroscience
2019-09-11 | Journal article
Contributors: Shilin Luo; Seong Su Kang; Zhi-Hao Wang; Xia Liu; Julia X Day; Zhiping Wu; Junmin Peng; Daxiong Xiang; Wolfdieter Springer; Keqiang Ye
Source: check_circle
Crossref

Puerarin-loaded PEG-PE micelles with enhanced anti-apoptotic effect and better pharmacokinetic profile

Drug Delivery
2018-01-01 | Journal article
Part of ISSN: 1071-7544
Part of ISSN: 1521-0464
Source: Self-asserted source
shilin Luo